Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunocompromised Patient”

281 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 281 results

Not applicableLooking for participantsNCT07529171
What this trial is testing

HBV Reactivation in Immunocompromised Patients (REANT STUDY)

Who this might be right for
HBV
Yaşar Bayındır, MD 490
Not applicableStudy completedNCT03389997
What this trial is testing

Assessement of Viral Shedding Duration After a Respiratory Tract Infection in Oncology and Hematology Patients

Who this might be right for
Respiratory Tract Viral Infection
Poitiers University Hospital 44
Not applicableUnknownNCT06432777
What this trial is testing

Recurrent Campylobacter Bacteraemia in Immunocompromised Patients

Who this might be right for
Campylobacter Infections
Hospices Civils de Lyon 30
Not applicableStudy completedNCT00134342
What this trial is testing

Tuberculosis (TB) Screening for the Diagnosis of Latent TB in Immunocompromised Populations

Who this might be right for
Tuberculosis
University Health Network, Toronto 203
Large-scale testing (Phase 3)Study completedNCT00735761
What this trial is testing

Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis in Immunocompromised Patients

Who this might be right for
Herpes Labialis
Medivir 201
Testing effectiveness (Phase 2)Study completedNCT00867139
What this trial is testing

TCAD vs. Monotherapy for Influenza A in Immunocompromised Patients

Who this might be right for
Influenza
Fred Hutchinson Cancer Center 7
Very early researchStudy completedNCT02687763
What this trial is testing

Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant

Who this might be right for
RENAL INSUFFICIENCY, CHRONICLIVER FAILURE, ACUTEHEART DISEASE
Medical University of South Carolina 5
Not applicableUnknownNCT06258551
What this trial is testing

Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients

Who this might be right for
Antimicrobial Drug ResistanceAntibiotic Resistant InfectionClostridium Difficile+5 more
The Methodist Hospital Research Institute 1,000
Post-approval studies (Phase 4)Not Yet RecruitingNCT06271681
What this trial is testing

Evaluation of PCV21 Vaccination Among PPSV23-experienced, Immunocompromised Elderly Veterans

Who this might be right for
Pneumococcal VaccinesImmunosuppression
VA Sierra Nevada Health Care System 45
Testing effectiveness (Phase 2)Ended earlyNCT03334240
What this trial is testing

ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients

Who this might be right for
HPV-Induced Genital Lesions
Maruho Co., Ltd. 28
Not applicableLooking for participantsNCT06612515
What this trial is testing

Vaccine-induced Immunity in Immunocompromised Patients

Who this might be right for
Immunodeficiency
University of Cologne 1,000
Not applicableUnknownNCT03920735
What this trial is testing

Retrospective Non-interventional Analysis of Opportunistic Infections in Immunocompromised and Frail Patients

Who this might be right for
Hematologic DiseaseNeoplamsTransplantation+2 more
University Hospital, Strasbourg, France 1,000
Large-scale testing (Phase 3)Not Yet RecruitingNCT06276504
What this trial is testing

Pembrolizumab in Progressive Multifocal Leukoencephalopathy (PML) in Immunocompromised Patients Without HIV Infection

Who this might be right for
Progressive Multifocal Leukoencephalopathy
Assistance Publique - Hôpitaux de Paris 33
Testing effectiveness (Phase 2)Looking for participantsNCT06599658
What this trial is testing

COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

Who this might be right for
COVID 19InfluenzaRheumatoid Arthritis (RA)+5 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 660
Not applicableStudy completedNCT00002025
What this trial is testing

Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient

Who this might be right for
Cytomegalovirus InfectionsCytomegalovirus RetinitisHIV Infections
Hoffmann-La Roche
Large-scale testing (Phase 3)Study completedNCT00361517
What this trial is testing

To Determine Whether Galactomannan Test Will Help to Detect Fungal Infections Early and Hence Start Treatment Early

Who this might be right for
Aspergillosis
Singapore General Hospital 47
Testing effectiveness (Phase 2)Looking for participantsNCT06817889
What this trial is testing

Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmAutoimmune DiseaseRespiratory Syncytial Virus Infection
Fred Hutchinson Cancer Center 60
Post-approval studies (Phase 4)Study completedNCT05305651
What this trial is testing

Study to Monitor the Occurrence of Viral Variants in Patients With Compromised Immune Systems Being Treated for COVID-19

Who this might be right for
COVID-19
GlaxoSmithKline 217
Not applicableLooking for participantsNCT05405491
What this trial is testing

Impact of a Strategy Based on Bacterial DNA Detection to Optimize Antibiotics in Immunocompromised Patients With Hospital-acquired Pneumonia Requiring Mechanical Ventilation

Who this might be right for
Pneumonia, Ventilator-AssociatedPneumonia, Hospital-AcquiredImmunodeficiency
University Hospital, Lille 31
Post-approval studies (Phase 4)Ended earlyNCT05057897
What this trial is testing

AZD1222, a Vaccine for the Prevention of COVID-19 in Immunocompromised Adults

Who this might be right for
COVID-19, SARS-CoV-2
AstraZeneca 34
Next Page